It was a book that was excerpted in The Saturday Evening Post, featured in Time magazine, reviewed enthusiastically in Annals of the American Academy of Political and Social Science, and recommended by Archives of Neurology and Psychiatry. It earned mixed reviews in The Journal of the American Medical Association and...
The Dinges Factor, Through the Years
The new issue of Penn Medicine (Fall 2012) has a cover story on the work of David F. Dinges, PhD, with the National Aeronautics and Space Administration (NASA). The article’s hook is the recent completion of the Mars-500 experiment, a multinational effort to simulate a manned mission to Mars. Six...
Art and Insanity
Was modern art insane? Was modern art -– often defined as art that broke from classical traditions in Europe beginning in the mid-19th century –- created by artists with mental diseases, for appreciation by those with sick minds? To hear what some Penn psychiatrists had to say in the 1920s,...
Psychiatry and Eugenics
The forthcoming Fall 2012 issue of Penn Medicine will include Part 1 of Marshall Ledger’s engrossing article on psychiatry at Penn. The article is timed to commemorate the 200th anniversary of the publication of Medical Inquiries and Observations, Upon the Diseases of the Mind, by Dr. Benjamin Rush, considered the...
Good Ideas, Both Old and New
As I was reading about the early years of the Department of Psychiatry of the Perelman School of Medicine recently, I came upon a surprising case of anticipation. Learning about a new program -- in 1949 -- reminded me once again that some ideas are good enough to go around more than once.
Integrating Knowledge – of All Sorts
If it wasn’t for Jonathan Moreno, PhD, bioethicist and historian of science, I might never have heard about Clyven, “The First Transgenic Mouse with Human Intelligence.” This “hu-mouse” is said to be so intelligent that he’ll answer your questions at the Web site of RYT Hospital. In the course of...
The Rickels Standard
“We need new and better ways to treat our patients, not just ‘me, too’ medications. We need new and daring approaches. Our patients deserve it!”


